Clinical trial
A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer
NCT00192114 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study of Oral Enzastaurin HCl in Patients With Metastatic Colorectal Cancer
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- March 31, 2008
- Enrollment
- 28 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.